Japan Lifeline Co., Ltd.

Tokyo Stock Exchange 7575.T

Japan Lifeline Co., Ltd. Shareholders' Equity for the year ending March 31, 2024: USD 383.87 M

Japan Lifeline Co., Ltd. Shareholders' Equity is USD 383.87 M for the year ending March 31, 2024, a -9.25% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Japan Lifeline Co., Ltd. Shareholders' Equity for the year ending March 31, 2023 was USD 422.99 M, a -5.64% change year over year.
  • Japan Lifeline Co., Ltd. Shareholders' Equity for the year ending March 31, 2022 was USD 448.27 M, a -3.24% change year over year.
  • Japan Lifeline Co., Ltd. Shareholders' Equity for the year ending March 31, 2021 was USD 463.27 M, a -3.09% change year over year.
  • Japan Lifeline Co., Ltd. Shareholders' Equity for the year ending March 31, 2020 was USD 478.02 M, a 14.00% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
Tokyo Stock Exchange: 7575.T

Japan Lifeline Co., Ltd.

CEO Mr. Keisuke Suzuki
IPO Date Jan. 4, 2000
Location Japan
Headquarters Tennoz Ocean Square
Employees 1,216
Sector Health Care
Industries
Description

Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company's cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts; and transvascular intervention products include PTCA and PTA guide wires, PTCA balloon catheters, radiofrequency wires, and atrial septal defect closure devices. The company offers gastrointestinal intervention products that consist of radiofrequency ablation systems, self-expandable colonic stents, and endoscopic guidewires. Japan Lifeline Co., Ltd. was incorporated in 1981 and is headquartered in Tokyo, Japan.

Similar companies

7988.T

Nifco Inc.

USD 24.16

0.61%

6849.T

Nihon Kohden Corporation

USD 14.45

-0.11%

6869.T

Sysmex Corporation

USD 19.46

-0.86%

4849.T

en-japan inc.

USD 13.29

1.45%

7747.T

Asahi Intecc Co., Ltd.

USD 17.23

0.90%

StockViz Staff

January 31, 2025

Any question? Send us an email